These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6682147)

  • 1. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors.
    Neumeyer JL; Reischig D; Arana GW; Campbell A; Baldessarini RJ; Kula NS; Watling KJ
    J Med Chem; 1983 Apr; 26(4):516-21. PubMed ID: 6682147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
    Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ
    J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE
    Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain.
    Kula NS; Baldessarini RJ; Bromley S; Neumeyer JL
    Life Sci; 1985 Sep; 37(11):1051-7. PubMed ID: 4033350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.
    Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL
    Psychopharmacology (Berl); 1986; 88(2):158-64. PubMed ID: 3081927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.
    Gao YG; Baldessarini RJ; Kula NS; Neumeyer JL
    J Med Chem; 1990 Jun; 33(6):1800-5. PubMed ID: 1971309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
    Campbell A; Baldessarini RJ; Ram VJ; Neumeyer JL
    Neuropharmacology; 1982 Oct; 21(10):953-61. PubMed ID: 6890636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
    Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL
    Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
    Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T
    J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors.
    Goldman ME; Kebabian JW
    Mol Pharmacol; 1984 Jan; 25(1):18-23. PubMed ID: 6231468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
    Campbell A; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1993; 111(3):351-8. PubMed ID: 7870974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
    Sperk G; Campbell A; Baldessarini RJ; Stoll A; Neumeyer JL
    Neuropharmacology; 1982 Dec; 21(12):1311-6. PubMed ID: 6891445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF; Neumeyer JL; Waszczak BL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.